Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes

Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes

US Patent 8722882 · Granted May 13, 2014

Estimated economic value: $117,499,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

High-performance ladder polymers for membrane gas separation2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
Pyridinone- and pyridazinone-based compounds and uses thereof2024
Intrinsically microporous ladder-type Tröger's base polymers2023
RNA formulations2023
Bicycloheptane pyrrolidine orexin receptor agonists2023
Antidiabetic heterocyclic compounds2021
2,2-difluorodioxolo A2A receptor antagonists2021
Relevance-ordered message search2021
Antidiabetic spirochroman compounds2021
Compounds inhibiting leucine-rich repeat kinase enzyme activity2021
Substituted tricyclic heterocyclic compounds and use thereof2021